Concepedia

Author

Theresia M. Westers

Amsterdam UMC Location Vrije Universiteit AmsterdamORCID

Also Known As

T M Westers, T. M. Westers, T. Westers, T.M. Westers, Theresia M Westers, Theresia M. Westers, Theresia Westers, Theresia M. Westers, Ulrika Johansson, Westers, T.M.

191

Publications

4K

Citations

34

H-Index

52

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit AmsterdamCancer Center AmsterdamRadboud University NijmegenErasmus MCRadboud University Medical Center
TM

About

Theresia M. Westers is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

24

1.3K

2

Health Sciences

11

12

980

3

Biostatistics

2

2

49

4

Allergy

1

1

37

5

Biomedical Engineering

1

1

22

Theresia M. Westers

×

51

Publications

3K

Citations

30

H-Index

YearCitations

Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia

Noemi A. Zambetti, Zhen Ping, Si Chen,

Cell stem cell

2016

322

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Theresia M. Westers, Robin Ireland, Wolfgang Kern,

Leukemia

2012

243

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Arjan A. van de Loosdrecht, Canan Alhan, Marie C. Béné,

Haematologica

2009

236

Identification of distinct prognostic subgroups in low- and intermediate-1–risk myelodysplastic syndromes by flow cytometry

Arjan A. van de Loosdrecht, Theresia M. Westers, August H. Westra,

Blood

2007

223

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Peter Valent, Attilio Orazi, David P. Steensma,

Oncotarget

2017

186

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

Matteo Giovanni Della Porta, Cristina Picone, Cristiana Pascutto,

Haematologica

2012

165

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Anna Porwit, Arjan A. van de Loosdrecht, Peter Bettelheim,

Leukemia

2014

145

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

Theresia M. Westers, Eline M.P. Cremers, Uta Oelschlaegel,

Haematologica

2016

96

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment

Theresia M. Westers, Canan Alhan, Martine E.D. Chamuleau,

Blood

2009

91

Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome

Martine E.D. Chamuleau, Theresia M. Westers, L. van Dreunen,

Haematologica

2009

70

Page 1